Araceli Biosciences announced a Stage undisclosed round of $4.5M on 13 November 2026. The company operates in HealthTech and is based in United States. Announced 5 days ago.
Raised
$4.5M
Stage
Stage undisclosed
Industry
HealthTech
Country
United States
Outreach angles
-Araceli Biosciences is a Tigard, Oregon startup selling instruments and software that image cells and automate their analysis.
-Its users include the Max Planck Institute, Evotec, Ginkgo Bioworks and large pharmaceutical companies.
-The $4.5M round, with Jeff Swickard joining as an investor, funds commercialisation and new products for human-cell alternatives to animal testing, taking total funding to $22.7M.